IMMUNOLOGY OF CYSTIC-FIBROSIS

被引:23
作者
WARNER, JO
机构
[1] Department of Child Health, University of Southampton, Southampton
关键词
D O I
10.1093/oxfordjournals.bmb.a072584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The combination of all the immunological abnormalities described in CF appear to have a final common pathway through effects on neutrophils. Potent neutrophil chemotactic factors are produced as a result of antibody-antigen interactions leading to complement activation and the generation of C5a and the many cytokines released as a result of cellular immune responses leading to neutrophil influx and activation. In addition, the product of bacterial metabolism fMLP also produces neutrophil chemotaxis. The activated neutrophils release a range of proteases and oxygen radicals which directly damage tissues. It can, therefore, be hypothesised that the excessive immune response is directly contributing to the tissue damage. Indeed, it is even possible that this is the principal cause of the lung function defect without invoking any direct influence of the infecting organisms. This, of course, has major implications for approaches to therapy. Currently the main focus is on suppression of the organisms. However, modulation of the immune response is an attractive alternative approach.
引用
收藏
页码:893 / 911
页数:19
相关论文
共 71 条
[1]  
ASSADULLAHI T P, 1992, American Review of Respiratory Disease, V145, pA118
[2]  
AUERBACH HS, 1985, LANCET, V2, P686
[3]  
BORREGAARD N, 1984, SCAND J HAEMATOL, V32, P225
[4]  
BRUCE MC, 1985, AM REV RESPIR DIS, V132, P529
[5]  
CARSWELL F, 1979, CLIN EXP IMMUNOL, V35, P141
[6]   PREVALENCE OF ATOPY AND EXERCISE-INDUCED BRONCHIAL LABILITY IN RELATIVES OF PATIENTS WITH CYSTIC-FIBROSIS [J].
COUNAHAN, R ;
MEARNS, MB .
ARCHIVES OF DISEASE IN CHILDHOOD, 1975, 50 (06) :477-481
[7]   RAISED SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR CONCENTRATIONS IN CYSTIC-FIBROSIS PATIENTS WITH AND WITHOUT EVIDENCE OF LUNG-DISEASE [J].
DAGLI, E ;
WARNER, JA ;
BESLEY, CR ;
WARNER, JO .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (04) :479-481
[8]  
DAGLI E, 1990, American Review of Respiratory Disease, V141, pA812
[9]  
DONATI MA, 1990, PEDIATR PULM, V5, pA277
[10]  
DORING G, 1988, CHEST S, V94, P109